Reporting adverse drug reactions in HIV infection.
作者信息
Arlett P R, Lee E H, Hooker M, Darbyshire J H, Breckenridge A M
出版信息
Genitourin Med. 1997 Oct;73(5):335. doi: 10.1136/sti.73.5.335.
Abstract
摘要
相似文献
1
Reporting adverse drug reactions in HIV infection.报告HIV感染中的药物不良反应。
Genitourin Med. 1997 Oct;73(5):335. doi: 10.1136/sti.73.5.335.
2
[HIV therapy from the viewpoint of the patient. Four out of five suffer with side-effects].
MMW Fortschr Med. 2000;142(3 Suppl):32-3.
3
Beyond lipodystrophy: will toxicity issues ever outweigh the benefits of HAART?除脂肪代谢障碍外：毒性问题会否超过高效抗逆转录病毒治疗的益处？
J HIV Ther. 2003 May;8(2):27-8.
4
Discordance between ambulatory care clinic and community pharmacy medication databases for HIV-positive patients.针对HIV阳性患者的门诊护理诊所与社区药房药物数据库之间的不一致情况。
J Am Pharm Assoc (2003). 2007 Sep-Oct;47(5):613-5. doi: 10.1331/JAPhA.2007.06131.
5
Addressing gaps in pharmacovigilance practices in the antiretroviral therapy program in the Eastern Cape Province, South Africa.解决南非东开普省抗逆转录病毒治疗方案中药物警戒实践方面的差距。
Res Social Adm Pharm. 2010 Dec;6(4):345-53. doi: 10.1016/j.sapharm.2009.11.006. Epub 2010 Feb 11.
6
Targeted spontaneous reporting of suspected renal toxicity in patients undergoing highly active anti-retroviral therapy in two public health facilities in Uganda.乌干达两家公共卫生机构中接受高效抗逆转录病毒治疗患者的疑似肾毒性靶向自发报告。
Drug Saf. 2015 Apr;38(4):395-408. doi: 10.1007/s40264-015-0277-9.
7
8
Influence of HCV or HBV coinfection on adverse drug reactions to antiretroviral drugs in HIV patients.丙型肝炎病毒（HCV）或乙型肝炎病毒（HBV）合并感染对HIV患者抗逆转录病毒药物不良反应的影响。
Eur J Clin Pharmacol. 2006 Mar;62(3):243-9. doi: 10.1007/s00228-005-0080-0. Epub 2006 Jan 17.
9
Adverse drug reactions to antiretroviral therapy (ART): an experience of spontaneous reporting and intensive monitoring from ART centre in India.抗逆转录病毒疗法（ART）的药物不良反应：来自印度 ART 中心的自发报告和强化监测经验。
Pharmacoepidemiol Drug Saf. 2010 Mar;19(3):247-55. doi: 10.1002/pds.1907.
10
Using registries to monitor HIV pre-exposure prophylaxis safety in clinical settings.利用登记系统监测临床环境中HIV暴露前预防的安全性。
Am J Prev Med. 2013 Jan;44(1 Suppl 2):S151-5. doi: 10.1016/j.amepre.2012.09.042.
本文引用的文献
1
Regulatory pharmacovigilance in the United Kingdom: current principles and practice.英国的监管药物警戒：当前原则与实践
Pharmacoepidemiol Drug Saf. 1996 Nov;5(6):363-75. doi: 10.1002/(SICI)1099-1557(199611)5:6<363::AID-PDS249>3.0.CO;2-7.
2
Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients: Part 2.成人HIV阳性患者常用治疗药物的不良反应及药物相互作用：第2部分。
Genitourin Med. 1997 Feb;73(1):5-11. doi: 10.1136/sti.73.1.5.
3
Adverse effects and drug interactions of medications commonly used in the treatment of adult HIV positive patients.成人HIV阳性患者治疗中常用药物的不良反应及药物相互作用。
Genitourin Med. 1996 Aug;72(4):237-46. doi: 10.1136/sti.72.4.237.
Zotero 插件